KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Work In Process (2018 - 2025)

Historic Work In Process for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to $2.3 million.

  • Twist Bioscience's Work In Process fell 1202.12% to $2.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.3 million, marking a year-over-year decrease of 1202.12%. This contributed to the annual value of $2.3 million for FY2025, which is 554.52% up from last year.
  • Per Twist Bioscience's latest filing, its Work In Process stood at $2.3 million for Q4 2025, which was down 1202.12% from $2.3 million recorded in Q3 2025.
  • Over the past 5 years, Twist Bioscience's Work In Process peaked at $4.8 million during Q3 2021, and registered a low of $611000.0 during Q2 2023.
  • Over the past 5 years, Twist Bioscience's median Work In Process value was $2.5 million (recorded in 2021), while the average stood at $2.5 million.
  • Its Work In Process has fluctuated over the past 5 years, first crashed by 8424.85% in 2023, then soared by 26219.31% in 2024.
  • Over the past 5 years, Twist Bioscience's Work In Process (Quarter) stood at $3.1 million in 2021, then rose by 14.86% to $3.6 million in 2022, then crashed by 33.8% to $2.4 million in 2023, then grew by 10.33% to $2.6 million in 2024, then decreased by 12.02% to $2.3 million in 2025.
  • Its Work In Process was $2.3 million in Q4 2025, compared to $2.3 million in Q3 2025 and $2.0 million in Q2 2025.